Investors

Press releases

2024/02/22

Medivir presents data that strengthens the fostrox/Lenvima combination in primary liver cancer at EASL Liver Cancer Summit

Read more
2024/02/15

MEDIVIR AB – YEAR-END REPORT JANUARY – DECEMBER 2023

Read more
2024/01/31

Number of shares and votes in Medivir AB on 31 January 2024

Read more

Presentations

Quarterly report presentations

Events

2024/03/07

Vator Swiss Nordic Bio 2024

Read more
2024/04/30

Interim Report, January - March 2024

Read more
2024/05/07

Annual General Meeting 2024

Read more

Corporate Governance

Medivir Corporate Governance documention.

Annual General Meeting

Documentation from Medivir's Annual General Meetings.